Discover How CDD Vault Empowers Collaborative Drug Discovery

Drug discovery company RIANA Therapeutics was spun out of the University of Veterinary Medicine, Vienna (Vetmeduni) in 2023 to develop small molecule anticancer therapeutics that target protein-protein interactions (PPIs) in what has traditionally been considered the largely undruggable molecular space of transcription factors.

VIB is a leading non-profit research institute in Belgium that brings together more than 1,500 scientists across five major universities to accelerate biological innovation.

With over 25 years of experience, Roopa has held leadership positions in discovery research in various therapeutic areas including oncology. She has a successful track record...

Libra Therapeutics is a San Diego-based biotech focused on developing novel disease-modifying therapeutics, which restore the cellular balance that is disrupted in neurodegenerative...

Via Nova Therapeutics deploys state-of-the-art drug discovery modalities to identify novel, first-in-class antivirals for the individual infections it studies....

Opna Bio is focused on the discovery and development of novel small molecule oncology therapeutics. Founded in 2019 in Lausanne, Switzerland, Opna is...

Psychedelic plants and fungi have been used medicinally by indigenous populations over thousands of years. But while psychedelic drug research has witnessed...

Plexium is an emerging biotechnology company focused on discovering and developing protein degrading therapeutics to treat cancer and other serious diseases...

The biggest asset for any drug discovery organization is the ability to access and analyze insightful, contextual, and actionable data, which then informs...

Agritech companies developing new herbicides generate and analyze huge amounts of data. Data from high-throughput screens, chemical optimization...

This case study explores how BioVersys transformed its data processes using CDD Vault to streamline collaboration, support regulatory demands, and enable real-time insight sharing across its AMR pipeline.